N-(tert-Butoxycarbonyl)-N-isopropylglycine

Catalog No. :
ACFCOB802
CAS No. :
154509-63-4
Molecular Formula :
C10H19NO4
Molecular Weight :
217.26

IUPAC Name:N-(tert-butoxycarbonyl)-N-isopropylglycine

N-(tert-Butoxycarbonyl)-N-isopropylglycine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$92.00Login to see priceIn stockIn stock
5g95%$277.00Login to see priceIn stockIn stock
25g95%$1260.00Login to see priceIn stockInquiry
100g95%$4536.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(tert-Butoxycarbonyl)-N-isopropylglycine
IUPAC NameN-(tert-butoxycarbonyl)-N-isopropylglycine
Molecular FormulaC10H19NO4
Molecular Weight217.26
SMILESO=C(O)CN(C(OC(C)(C)C)=O)C(C)C
InChI KeyVDWLWSLMCAPRCS-UHFFFAOYSA-N
SynonymN-BOC-N-ISOPROPYL-AMINO-ACETIC ACID;N-Boc-N-(1-methylethyl)glycine;(tert-Butoxycarbonyl-isopropyl-amino)-acetic acid;2-{[(tert-butoxy)carbonyl](propan-2-yl)amino}acetic acid;N-Isopropylglycine, N-BOC protected;Boc-N(iPr)Gly-OH;Glycine, N-[(1,1-dimethylethoxy)carbonyl]-N-(1-methylethyl)-;N-Boc-N-isopropylamino-acetic ac
CAS No.154509-63-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACFCOB802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFCOB802 route product structure diagram
    ACFCOB802154509-63-4 In Stock
Inquiry

2. ACFCOB802 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFCOB802 route product structure diagram
    ACFCOB802154509-63-4 In Stock
Inquiry

Comments (0)